Table of Contents

• What Are Melanocortin Research Peptides?
• Which Compounds Are Available in the True Peptide Labs Melanocortin Category?
• What Is the Melanocortin Receptor Family?
• What Are the Endogenous Melanocortin Ligands?
• What Are the Categories of Melanocortin Research Peptides?
• Which Melanocortin Research Peptides Are Most Studied?
• What Is the Importance of Melanocortin Research Peptides in Preclinical Science?
• What Research Protocols Are Described in the Melanocortin Peptide Literature?
• How Is Receptor Selectivity Characterized in Melanocortin Peptide Research?
• What Concentration Ranges Appear in Published Melanocortin Peptide Studies?
• What Endpoints Are Measured in Melanocortin Peptide Research?
• What Downstream Signaling Pathways Do Melanocortin Receptors Engage?
• What Model Systems Are Used in Melanocortin Peptide Research?
• What Adverse Events Have Been Reported in the Melanocortin Peptide Research Literature?
• In What Form Do Melanocortin Research Peptides Ship?
• How Are Melanocortin Research Peptides Tested for Purity?
• How to Purchase Melanocortin Research Peptides Online
• What Is the Difference Between Melanocortin and Neuroendocrine Research Peptides?

What Are Melanocortin Research Peptides?

Melanocortin research peptides are synthetic peptide compounds used in laboratory studies to investigate the melanocortin receptor family and its downstream signaling pathways in vitro receptor-transfected cell lines, primary cell cultures expressing endogenous melanocortin receptors, and rodent receptor-characterization models. These compounds act at the melanocortin-1 receptor (MC1R), the melanocortin-3 receptor (MC3R), the melanocortin-4 receptor (MC4R), and the melanocortin-5 receptor (MC5R), with varying receptor selectivity profiles. The class is defined by structural derivation from or activity at the melanocortin peptide family, per the pharmacological framework described in the Cone laboratory publications at Vanderbilt University and the broader melanocortin receptor pharmacology literature.

Which Compounds Are Available in the True Peptide Labs Melanocortin Category?

The compounds available in the True Peptide Labs melanocortin research category, organized by receptor selectivity profile, are listed below. Each compound links to its dedicated product page with certificate of analysis, primary literature references, and lot-specific purity data.

• PT-141 (10 mg) — Cyclic heptapeptide melanocortin receptor agonist with selectivity for MC3R and MC4R, studied in the central nervous system melanocortin pharmacology literature
• Melanotan II (10 mg) — Cyclic α-MSH analog with broad activity across MC1R, MC3R, MC4R, and MC5R, studied as a research tool for melanocortin receptor characterization and structure-activity analysis

Each compound ships as lyophilized powder with a lot-specific certificate of analysis. Individual product pages provide the sequence, molecular weight, purity data, and primary literature citations for that specific compound.

What Is the Melanocortin Receptor Family?

The melanocortin receptor family consists of five class A G-protein-coupled receptors (MC1R through MC5R) that share sequence homology and couple predominantly to Gs to activate adenylyl cyclase and elevate intracellular cyclic AMP (cAMP). The five receptors are distinguished by tissue distribution, endogenous ligand affinity, and endogenous antagonist regulation:

1. MC1R — expressed predominantly on melanocytes, studied for pigmentation and melanogenesis signaling in the melanocyte biology literature.
2. MC2R — the ACTH receptor, expressed predominantly on adrenocortical cells, studied in the adrenal steroidogenesis literature. MC2R is unique in the family in that it requires the melanocortin receptor accessory protein (MRAP) for cell-surface expression and is activated selectively by ACTH.
3. MC3R — expressed in hypothalamic nuclei including the arcuate nucleus and in limbic regions, studied for energy homeostasis and central nervous system melanocortin signaling.
4. MC4R — expressed throughout the paraventricular nucleus of the hypothalamus and in the brainstem, studied extensively in the energy balance and central melanocortin signaling literature.
5. MC5R — expressed in exocrine glands and peripheral tissues, studied for effects on sebaceous and other exocrine gland function.

What Are the Endogenous Melanocortin Ligands?

The endogenous melanocortin ligands are derived from post-translational processing of proopiomelanocortin (POMC), a precursor protein encoded by the POMC gene. Prohormone convertase enzymes cleave POMC differentially in different tissues to generate the following bioactive peptides:

1. α-melanocyte-stimulating hormone (α-MSH) — a 13-amino acid peptide (Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH₂) that acts at MC1R, MC3R, MC4R, and MC5R; the reference endogenous agonist for the family.
2. β-melanocyte-stimulating hormone (β-MSH) — an 18-amino acid peptide with activity across the receptor family.
3. γ-melanocyte-stimulating hormone (γ-MSH) — a peptide with relative selectivity for MC3R over other family members.
4. Adrenocorticotropic hormone (ACTH) — a 39-amino acid peptide, the selective endogenous agonist for MC2R and a full agonist across the other family members.
5. Agouti-signaling protein (ASIP) and agouti-related peptide (AgRP) — endogenous inverse agonists / antagonists that regulate melanocortin signaling in specific tissues; ASIP acts predominantly at MC1R while AgRP acts predominantly at MC3R and MC4R.

What Are the Categories of Melanocortin Research Peptides?

The categories of melanocortin research peptides, organized by structural class and receptor selectivity, are as follows:

1. Linear α-MSH analogs — modified linear peptides based on the α-MSH sequence with substitutions at key residues (typically the His-Phe-Arg-Trp core pharmacophore) to alter receptor affinity, selectivity, and metabolic stability.
2. Cyclic α-MSH analogs — including Melanotan II, in which the peptide backbone is constrained by a lactam bridge to reduce conformational flexibility and produce broad, high-affinity binding across MC1R, MC3R, MC4R, and MC5R.
3. MC3R/MC4R-selective ligands — including PT-141, cyclic peptides engineered to bind MC3R and MC4R with reduced activity at MC1R and MC5R, useful as tools for dissecting central versus peripheral melanocortin signaling.
4. MC4R-selective agonists and antagonists — including the setmelanotide-class research analogs studied for central melanocortin signaling characterization.
5. γ-MSH-derived MC3R-preferring compounds — analogs preserving γ-MSH's relative MC3R selectivity for MC3R-specific pharmacological dissection.

Which Melanocortin Research Peptides Are Most Studied?

The melanocortin research peptides with the largest published footprint include the endogenous α-MSH peptide and its cyclic analog Melanotan II, characterized across more than 2,000 indexed publications spanning receptor pharmacology, structure-activity relationships, and species-comparison studies. PT-141 has been characterized in the MC3R/MC4R-selective ligand literature as a research tool for dissecting central melanocortin signaling. The broader melanocortin receptor field has produced more than 15,000 indexed publications since the cloning of the individual receptors in the 1990s, with the Cone laboratory at Vanderbilt University anchoring the modern synthesis of the field's pharmacology. Individual product pages in this category link to the primary literature for each specific compound.

What Is the Importance of Melanocortin Research Peptides in Preclinical Science?

Melanocortin research peptides are important to preclinical science because they are the primary experimental tools for probing the pharmacology of the melanocortin receptor family — one of the most widely studied G-protein-coupled receptor families in mammalian biology. Compounds in this category enable the dissection of receptor-specific and pathway-specific effects that would be impossible to study with the endogenous ligands alone, given the broad receptor promiscuity of α-MSH. The cloning of MC1R, MC3R, MC4R, and MC5R at the Cone laboratory and collaborating groups in the early 1990s established the pharmacological framework used across the field today. Compounds in this category inform mechanism-of-action understanding for the melanocortin-cAMP-CREB signaling axis, the MC4R hypothalamic energy-balance model, and the MC1R melanocyte biology framework in the peer-reviewed literature.

What Research Protocols Are Described in the Melanocortin Peptide Literature?

Published preclinical protocols for melanocortin peptides typically describe assay systems (radioligand binding at cloned receptors expressed in HEK293 or CHO cells, functional cAMP accumulation assays, and β-arrestin recruitment assays), administration routes for in vivo work (subcutaneous, intraperitoneal, and intracerebroventricular for central mechanism studies), and endpoint measurements specific to each receptor and research question. Study designs include radioligand competition binding assays for affinity (Ki) determination, dose-response cAMP accumulation for potency (EC50) and efficacy (Emax) characterization, and receptor knockout mouse models for receptor-specific effect assignment. Researchers must consult peer-reviewed methodology sections and obtain approval from their institution's IACUC or IRB before designing any in vivo study, per NIH Office of Laboratory Animal Welfare guidance.

How Is Receptor Selectivity Characterized in Melanocortin Peptide Research?

Receptor selectivity in melanocortin peptide research is characterized through parallel assays at each of the five melanocortin receptors, typically expressed in HEK293 or CHO cells transfected with cDNA for the individual receptor. Selectivity is quantified as the ratio of binding affinities (Ki) or functional potencies (EC50) across receptors:

1. Radioligand competition binding — using ¹²⁵I-NDP-α-MSH or similar radioligand and measuring displacement by unlabeled test compound to determine Ki at each receptor.
2. Functional cAMP accumulation — measured by cAMP-Glo, HTRF cAMP, or reporter-gene assays to determine EC50 and Emax at each receptor.
3. β-arrestin recruitment — measured by PathHunter, BRET, or Tango assays to characterize G-protein-independent signaling and biased agonism.
4. Selectivity ratio — calculated as the ratio of EC50 values at the target receptor versus off-target receptors; a 100-fold ratio is a common threshold for "selective" designation.
5. Species comparison — the same compound tested at mouse, rat, and human orthologs of each receptor, as species differences in melanocortin pharmacology are well documented.

What Concentration Ranges Appear in Published Melanocortin Peptide Studies?

Concentration ranges in the published melanocortin peptide literature vary substantially by compound, receptor, assay system, and endpoint. Reported ranges span, for reference: nanomolar to low-micromolar affinities at MC3R and MC4R for cyclic α-MSH analogs and MC3R/MC4R-selective ligands in radioligand binding assays; subnanomolar to nanomolar EC50 values for full agonists in functional cAMP assays at MC1R and MC4R; and microgram-per-kilogram to low-milligram-per-kilogram dose ranges in rodent in vivo receptor-characterization studies via subcutaneous and intraperitoneal routes. Model systems include HEK293 and CHO cell lines transfected with cloned MC1R, MC3R, MC4R, or MC5R; primary murine hypothalamic cultures for endogenous MC4R signaling; C57BL/6J and receptor-knockout mice for in vivo receptor-specific effects; and B16 murine melanoma cells for MC1R and melanogenesis research. Specific compound product pages link to the primary literature where researchers can review the exact concentration ranges reported for each study. This information is provided as literature reference only and does not constitute a recommendation for use.

What Endpoints Are Measured in Melanocortin Peptide Research?

The endpoints measured in melanocortin peptide research are as follows:

1. Receptor binding affinity (Ki) — quantified by radioligand competition binding at each of the five cloned melanocortin receptors.
2. Functional potency (EC50) and efficacy (Emax) — quantified in cAMP accumulation assays as the standard functional readout.
3. β-arrestin recruitment — measured to characterize functional selectivity and biased agonism at melanocortin receptors.
4. Receptor internalization — quantified by fluorescence microscopy or ELISA-based surface-receptor assays following ligand exposure.
5. Second messenger dose-response — including cAMP, IP3, and calcium mobilization where relevant to receptor-specific coupling.
6. Species-comparison pharmacology — parallel assays at mouse, rat, and human orthologs of each receptor.
7. Tissue-specific gene expression — measured by qPCR for CREB target genes downstream of Gs/cAMP signaling.
8. c-Fos immunoreactivity — used as a marker of neuronal activation in specific hypothalamic and brainstem nuclei following in vivo compound administration.
9. MC1R melanogenesis endpoints — melanin content quantification in B16 melanoma cells and primary melanocyte cultures.

What Downstream Signaling Pathways Do Melanocortin Receptors Engage?

The downstream signaling pathways engaged by the melanocortin receptor family are as follows:

1. Gs / adenylyl cyclase / cAMP — the primary and best-characterized signaling pathway for all five melanocortin receptors, driving elevation of intracellular cAMP.
2. Protein kinase A (PKA) — activated downstream of cAMP elevation, phosphorylating a wide range of substrate proteins including the transcription factor CREB.
3. cAMP response element binding protein (CREB) — phosphorylated by PKA to drive transcription of CREB target genes.
4. MAPK / ERK1/2 — engaged downstream of some melanocortin receptors in a receptor- and cell-type-dependent manner.
5. β-arrestin-mediated signaling — G-protein-independent pathways characterized for biased-agonism research.
6. Gq / phospholipase C / IP3 / calcium — a secondary coupling described for certain melanocortin receptors under specific conditions in the receptor pharmacology literature.
7. MITF and tyrosinase pathway — the transcriptional and enzymatic pathway downstream of MC1R signaling in melanocyte biology, driving melanin synthesis.

What Model Systems Are Used in Melanocortin Peptide Research?

The model systems used in melanocortin peptide research are as follows:

1. HEK293 cells transfected with cloned melanocortin receptors — the standard heterologous expression system for receptor binding and functional characterization.
2. CHO cells transfected with cloned receptors — an alternative heterologous system with different lipid environment characteristics.
3. B16 murine melanoma cells — the classical MC1R-expressing cell line for melanogenesis research.
4. Primary murine melanocyte cultures — for MC1R signaling in the physiological cellular context.
5. Primary hypothalamic neuron cultures — for endogenous MC3R and MC4R signaling in neurons expressing native receptor levels.
6. Wild-type and receptor-knockout mice — including MC3R-/- and MC4R-/- strains for receptor-specific effect assignment in vivo.
7. Agouti-yellow (Ay/a) mice — a natural genetic model of ectopic agouti expression that antagonizes MC1R and central melanocortin signaling.
8. C57BL/6J mice — the standard background strain for melanocortin receptor pharmacology.

What Adverse Events Have Been Reported in the Melanocortin Peptide Research Literature?

The adverse events reported in the published preclinical and clinical trial literature for melanocortin research peptides include injection-site observations (erythema, transient inflammation) for parenteral administration, dose-dependent effects on pigmentation and appetite documented in the preclinical record for broad-activity melanocortin agonists, and, for compounds with human clinical research, dose-dependent effects documented in the trial safety data submitted to regulatory agencies. Melanocortin receptor agonists in general have documented dose-related observations that vary by receptor selectivity profile, with broad-activity compounds carrying different profiles from selective ligands. Some studies have found variable event rates that may be partly due to differences in formulation, route, and titration schedule across trials. Researchers must review the full published safety data — including regulatory-agency briefing documents where applicable — for any specific compound before designing a study.

In What Form Do Melanocortin Research Peptides Ship?

Melanocortin research peptides from True Peptide Labs ship as lyophilized (freeze-dried) peptide powder in sealed sterile vials, packaged with a lot-specific certificate of analysis (COA) documenting purity by HPLC and mass by MS. Unopened vials are typically stored refrigerated at 2–8°C per the storage instructions on the COA, and reconstituted material is stored per the published stability data for the specific compound. Cold-pack shipping options are available for temperature-sensitive compounds. All orders ship from the True Peptide Labs facility in Palm Beach Gardens, Florida.

How Are Melanocortin Research Peptides Tested for Purity?

Melanocortin research peptides at True Peptide Labs are tested every lot by third-party ISO-accredited analytical laboratories using high-performance liquid chromatography (HPLC) for purity determination and mass spectrometry (MS) for molecular weight confirmation. Certificates of analysis are lot-specific and are available on each product page or by request. Testing methodology follows the analytical standards described in the United States Pharmacopeia (USP) general chapter <1503> for peptide characterization.

How to Purchase Melanocortin Research Peptides Online

Melanocortin research peptides can be purchased directly through the True Peptide Labs catalog on this page. Products are sold exclusively for research use by qualified researchers, laboratories, and institutions, and are not available for human use. All orders ship from the Palm Beach Gardens, Florida facility with standard shipping and cold-pack options for temperature-sensitive compounds. By purchasing, buyers affirm the material will not be administered to humans or animals outside of an approved research protocol reviewed by their institution's IACUC or IRB.

What Is the Difference Between Melanocortin and Neuroendocrine Research Peptides?

Melanocortin research peptides are defined by activity at the melanocortin receptor family (MC1R–MC5R) — a specific G-protein-coupled receptor family with characterized pharmacology across melanocyte, adrenal, hypothalamic, and exocrine gland targets. Neuroendocrine research peptides are defined more broadly by target activity in the hypothalamic-pituitary axis and its downstream hormone-signaling systems, including sleep-architecture peptides, kisspeptin-family reproductive-axis regulators, and neurohypophyseal peptides. The two categories overlap at the level of hypothalamic MC4R signaling, which is a central node in energy-balance research that intersects with the broader neuroendocrine pituitary literature. The dedicated neuroendocrine research peptides category page covers DSIP, kisspeptin, and oxytocin under their primary hypothalamic-pituitary framework.